Contact
searchSearch
HMP Global

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

August 2012 - FRMC

Physicians Surveyed about Strategies to Contain Costs
08/14/2013
Strategies suggested to curb increasing healthcare costs in the United States often focus on physicians, calling for reductions in waste and increased conservative stewardship of resources. Noting the importance of physicians’ perspectives on...
Strategies suggested to curb increasing healthcare costs in the United States often focus on physicians, calling for reductions in waste and increased conservative stewardship of resources. Noting the importance of physicians’ perspectives on...
Strategies suggested to curb...
08/14/2013
First Report Managed Care
MEK Inhibition in BRAF-Mutated Melanoma
08/16/2012
Until recently, there was no systemic therapy shown to improve overall survival among patients with metastatic melanoma, and only modest improvements were observed with interferon as an adjuvant drug. Ipilimumab, a monoclonal antibody...
Until recently, there was no systemic therapy shown to improve overall survival among patients with metastatic melanoma, and only modest improvements were observed with interferon as an adjuvant drug. Ipilimumab, a monoclonal antibody...
Until recently, there was no...
08/16/2012
First Report Managed Care
Combination Chemotherapy in Advanced Adrenocortical Carcinoma
08/16/2012
The 5-year survival rate for adrenocortical carcinoma, a rare cancer with a poor prognosis, is <15% among patients with metastatic disease. Mitotane is the only drug approved for the treatment of adrenocortical carcinoma and is used both...
The 5-year survival rate for adrenocortical carcinoma, a rare cancer with a poor prognosis, is <15% among patients with metastatic disease. Mitotane is the only drug approved for the treatment of adrenocortical carcinoma and is used both...
The 5-year survival rate for...
08/16/2012
First Report Managed Care
Rapid Whole-Genome Sequencing in a Neonatal MRSA Outbreak
08/16/2012
Although rapid whole-genome sequencing has been successfully used as a research tool with discriminatory power in outbreaks, it is also potentially useful for its possible clinical utility in a diagnostic setting. A compelling target is...
Although rapid whole-genome sequencing has been successfully used as a research tool with discriminatory power in outbreaks, it is also potentially useful for its possible clinical utility in a diagnostic setting. A compelling target is...
Although rapid whole-genome...
08/16/2012
First Report Managed Care
Radioiodine Ablation in Patients with Low-Risk Thyroid Cancer
08/16/2012
The administration of radioiodine (131I) has traditionally been part of therapy to patients with thyroid cancer after thyroidectomy; however, it is unclear whether this administration provides any benefit after a complete surgical resection....
The administration of radioiodine (131I) has traditionally been part of therapy to patients with thyroid cancer after thyroidectomy; however, it is unclear whether this administration provides any benefit after a complete surgical resection....
The administration of...
08/16/2012
First Report Managed Care
Patterns of Antiamyloid-β Antibodies in Typical and Atypical Alzheimer Disease
08/16/2012
A major feature of Alzheimer disease (AD) is the deposition of brain amyloid-β (Aβ) peptide. IgG antibodies directed to Aβ naturally occur in the elderly, and their serum and cerebrospinal fluid levels may be significantly altered in the...
A major feature of Alzheimer disease (AD) is the deposition of brain amyloid-β (Aβ) peptide. IgG antibodies directed to Aβ naturally occur in the elderly, and their serum and cerebrospinal fluid levels may be significantly altered in the...
A major feature of Alzheimer...
08/16/2012
First Report Managed Care
Ablation with Low-Dose Radioiodine and Thyrotropin Alfa in Thyroid Cancer
08/16/2012
Thyroid cancer is the most common endocrine cancer, with >48,000 new cases occurring each year in the United States. Most cases are differentiated thyroid cancer, which is associated with a high 10-year survival rate of 90% to 95%. Many...
Thyroid cancer is the most common endocrine cancer, with >48,000 new cases occurring each year in the United States. Most cases are differentiated thyroid cancer, which is associated with a high 10-year survival rate of 90% to 95%. Many...
Thyroid cancer is the most...
08/16/2012
First Report Managed Care
Short Sleep Duration and Risk for Strokes
08/16/2012
Boston—Researchers found an association between adults of normal weight sleeping <6 hours per night and an increased risk of stroke symptoms, according to an analysis of 5666 people who were part of a large study that has tracked patients...
Boston—Researchers found an association between adults of normal weight sleeping <6 hours per night and an increased risk of stroke symptoms, according to an analysis of 5666 people who were part of a large study that has tracked patients...
Boston—Researchers found an...
08/16/2012
First Report Managed Care
Zolpidem Tartrate Sublingual Tablets to Treat Insomnia
08/16/2012
Boston—According to a post hoc analysis of a double-blind, placebo-controlled cross-over study, patients who took 1.75 mg and 3.5 mg of zolpidem tartrate sublingual tablets had a significantly shorter time to sleep compared with those who...
Boston—According to a post hoc analysis of a double-blind, placebo-controlled cross-over study, patients who took 1.75 mg and 3.5 mg of zolpidem tartrate sublingual tablets had a significantly shorter time to sleep compared with those who...
Boston—According to a post hoc...
08/16/2012
First Report Managed Care
Aggressive BP Treatment Has No Benefit in Cardiovascular Disease Risk
08/16/2012
Philadelphia—A subanalysis of a major randomized blood pressure trial found that patients who are centrally obese and have type 2 diabetes do not benefit in terms of cardiovascular disease risk when they are treated aggressively to lower...
Philadelphia—A subanalysis of a major randomized blood pressure trial found that patients who are centrally obese and have type 2 diabetes do not benefit in terms of cardiovascular disease risk when they are treated aggressively to lower...
Philadelphia—A subanalysis of a...
08/16/2012
First Report Managed Care

Advertisement

Advertisement

Advertisement

FRMC Volume 21, Issue 3

Current Issue

September 2024
Volume 21
Issue 3
Current Issue
Issue Archive

Advertisement

Advertisement

What's Trending?

News
New Approach Shows Promise for Treating Advanced Stage Ovarian Cancer in Lab
11/28/2014
A recombinant version of thrombospondin-1 type I repeats (3TSR) in combination with chemotherapy shows promise in a mouse model of advanced stage epithelial ovarian cancer.
A recombinant version of thrombospondin-1 type I repeats (3TSR) in combination with chemotherapy shows promise in a mouse model of advanced stage epithelial ovarian cancer.
A recombinant version of...
11/28/2014
First Report Managed Care
News
Cost of Autologous Stem Cell Transplant for Multiple Myeloma Decreasing
12/06/2017
Research presented at ASH 2017 will highlight how costs for autologous stem cell transplantation have decreased over the past decade.
Research presented at ASH 2017 will highlight how costs for autologous stem cell transplantation have decreased over the past decade.
Research presented at ASH 2017...
12/06/2017
First Report Managed Care
COPD Projected to be Third Leading Cause of Death by 2020
11/14/2014
Chronic obstructive pulmonary disease (COPD) is the leading cause of morbidity and mortality worldwide, and by 2020, COPD will be the third leading cause of mortality.
Chronic obstructive pulmonary disease (COPD) is the leading cause of morbidity and mortality worldwide, and by 2020, COPD will be the third leading cause of mortality.
Chronic obstructive pulmonary...
11/14/2014
First Report Managed Care
News
Debt-limit deal triggers lobbying campaign from health-care and defense industries
08/04/2011
08/04/2011
First Report Managed Care
News
Walgreens: no new Medicaid patients as of April 16
03/18/2010
03/18/2010
First Report Managed Care

Video Insights

Videos
Bridging the Gaps in Prior Authorization: Challenges, Solutions, and Collaboration for Better Patient Care
11/13/2024
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief...
11/13/2024
First Report Managed Care
Richard Lipton, MD
Videos
The Evolving Role of CGRP-targeting Therapies in Migraine Prevention
10/31/2024
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides...
10/31/2024
First Report Managed Care
Alexander Spira, MD, PhD
Videos
Unmet Needs in the Treatment and Management of Non–Small Cell Lung Cancer
09/26/2024
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD,...
09/26/2024
First Report Managed Care
Videos
Treatment Options for NSCLC: A Discussion on Coverage, Clinical Outcomes, and Payer Perspectives
09/25/2024
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research...
09/25/2024
First Report Managed Care
Title Card
Videos
Addressing the Root Cause of a Common Ocular Condition: A Virtual Roundtable
09/04/2024
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on...
09/04/2024
First Report Managed Care
Jordan Bazinsky
Videos
Addressing Health Disparities and Promoting Equity: The Role of Advanced Imaging Solutions
08/15/2024
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky...
08/15/2024
First Report Managed Care
Farrukh Awan, MD
Videos
Promising Therapies and Clinical Trials for Chronic Lymphocytic Leukemia
08/14/2024
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights...
08/14/2024
Journal of Clinical Pathways
Hayward
Videos
Evolving Health Care Contact Centers Into Drivers of Value-Based Care
07/31/2024
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact...
07/31/2024
First Report Managed Care
Lucille Accetta Headshot
Videos
Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024
06/11/2024
Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health...
06/11/2024
First Report Managed Care
Melissa Andel, Principal, CommonHealth Solutions, LLC
Videos
Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers
05/24/2024
Melissa Andel, Principal, CommonHealth Solutions, LLC
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the...
05/24/2024
First Report Managed Care

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

August 2012 Volume 9 Issue 8

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement